Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Dark Pool Levels

CFX
Colfax Corporation
stock NYSE

Inactive
Apr 4, 2022
117.18USD-3.769%(-4.59)984,448
Pre-market
0.00USD-100.000%(-121.77)0
After-hours
0.00USD0.000%(0.00)0
OverviewPrice & VolumeSplitsHistoricalExchange VolumeDark Pool LevelsDark Pool PrintsExchangesShort VolumeShort Interest - DailyShort InterestBorrow Fee (CTB)Failure to Deliver (FTD)ShortsTrendsNewsNews
Jan 31, 2022
06:00PM EST  MEDIA ADVISORY - Canfor Pulp Products Inc. and Canfor Corporation Announce   PR Newswire
Jan 28, 2022
10:18AM EST  Where Colfax Stands With Analysts   Benzinga
07:48AM EST  Morgan Stanley Maintains Equal-Weight on Colfax, Lowers Price Target to $45   Benzinga
Jan 20, 2022
05:00PM EST  Colfax Schedules Fourth Quarter and Fiscal Year 2021 Earnings   GlobeNewswire Inc
Jan 14, 2022
09:07AM EST  Morgan Stanley Maintains Equal-Weight on Colfax, Lowers Price Target to $51   Benzinga
Jan 10, 2022
07:54AM EST  Colfax to Present at the 40th Annual JP Morgan Healthcare Conference   GlobeNewswire Inc
Jan 6, 2022
02:59PM EST  Loop Capital Is Bullish On Lincoln Electric; Initiates Colfax With Hold   Benzinga
10:06AM EST  Benzinga's Top Ratings Upgrades, Downgrades For January 6, 2022   Benzinga
08:23AM EST  Loop Capital Initiates Coverage On Colfax with Hold Rating, Announces Price Target of $45   Benzinga
Dec 30, 2021
04:13PM EST  Colfax Announces Plans For Reverse Stock Split   Benzinga
Dec 22, 2021
07:00PM EST  Canfor Pulp Announces Extended Production Outage at Northwood Pulp Mill   PR Newswire
Dec 2, 2021
07:00PM EST  Canfor Pulp Products Inc. Announces Production Curtailments in Response to   PR Newswire
Nov 5, 2021
10:26AM EDT  UPDATE: KeyBanc On Colfax Price Target Raise: Firm Encouraged By 'Sustained Momentum In FabTech & Anticipates MedTech Margins To Improve' As Elective Surgery Rates Normalize; Notes Auto Demand Lagging But Able To Drive Incremental Upside Into FY22   Benzinga
09:36AM EDT  Keybanc Maintains Overweight on Colfax, Raises Price Target to $60   Benzinga
Nov 4, 2021
08:10AM EDT  Colfax Clocks 20% Sales Growth In Q3, Beats Estimates   Benzinga
06:23AM EDT  Colfax Q3 EPS $0.54 Beats $0.53 Estimate, Sales $966.00M Beat $958.43M Estimate   Benzinga
06:00AM EDT  Colfax Corporation Announces Third Quarter 2021 Results   GlobeNewswire Inc
05:00AM EDT  Earnings Scheduled For November 4, 2021   Benzinga
Oct 26, 2021
06:00PM EDT  Canfor Pulp Reports Results for Third Quarter of 2021   PR Newswire
10:34AM EDT  Looking Into Colfax's Return On Capital Employed   Benzinga
04:39AM EDT  Earnings Scheduled For October 26, 2021   Benzinga
Oct 20, 2021
10:14AM EDT  Benzinga's Top Ratings Upgrades, Downgrades For October 20, 2021   Benzinga
Oct 18, 2021
10:45AM EDT  Colfax Schedules Third Quarter 2021 Earnings Release and   GlobeNewswire Inc
Oct 7, 2021
09:05AM EDT  Morgan Stanley Maintains Equal-Weight on Colfax, Lowers Price Target to $50   Benzinga
Oct 4, 2021
07:28AM EDT  Barclays Maintains Underweight on Colfax, Lowers Price Target to $43   Benzinga
Sep 29, 2021
06:00PM EDT  Media Advisory - Canfor Pulp Products Inc. and Canfor Corporation Announce   PR Newswire
Sep 10, 2021
10:06AM EDT  Benzinga's Top Ratings Upgrades, Downgrades For September 10, 2021   Benzinga
05:29AM EDT  Goldman Sachs Downgrades Colfax to Neutral, Lowers Price Target to $51   Benzinga
Aug 7, 2021
11:36AM EDT  Last Week's Notable Insider Buys: Magnolia Oil & Gas, Vertex Pharmaceuticals   Benzinga
11:35AM EDT  Last Week's Notable Insider Buys: Magnolia Oil & Gas, Vertex Pharmaceuticals And More   Benzinga
Aug 6, 2021
10:54AM EDT  Return on Capital Employed Overview: Colfax   Benzinga
Jul 30, 2021
11:54AM EDT  Morgan Stanley Maintains Equal-Weight on Colfax, Raises Price Target to $51   Benzinga
Jul 29, 2021
06:00PM EDT  Canfor Pulp Reports Results for Second Quarter of 2021   PR Newswire
09:53AM EDT  Colfax Late Wednesday Announced Pricing Of Secondary Offering Of ~6.54M Shares Of Common Stock   Benzinga
04:23AM EDT  Earnings Scheduled For July 29, 2021   Benzinga
Jul 28, 2021
04:51PM EDT  Colfax Sees Q3 EPS $0.50-$0.55 Vs. $0.56 Est., Raises FY21 EPS Guidance From $2.05-$2.15 To $2.10-$2.20 Vs. $2.07 Est.   Benzinga
04:49PM EDT  Colfax Q2 EPS $0.56 Beats $0.53 Estimate, Sales $986.00M Beat $917.93M Estimate   Benzinga
04:35PM EDT  Colfax Announced It Has Commenced An Unwritten Secondary Offering Of 6,544,522 Shares Of Common Stock. The Company Is Not Selling Any Shares Of Common Stock In The Offering And Will Receive No Proceeds From The Offering.   Benzinga
10:43AM EDT  A Preview Of Colfax's Earnings   Benzinga
Jul 14, 2021
05:37PM EDT  Colfax Schedules Second Quarter 2021 Earnings Release and   GlobeNewswire Inc
Jul 12, 2021
05:01PM EDT  Media Advisory - Canfor Corporation and Canfor Pulp Products Inc. Announce   PR Newswire
Jun 15, 2021
06:00PM EDT  Canfor Corporation and Canfor Pulp Products Inc. Announces Appointment of   PR Newswire
Apr 30, 2021
08:07AM EDT  Morgan Stanley Maintains Equal-Weight on Colfax, Raises Price Target to $47   Benzinga
Apr 29, 2021
08:01AM EDT  Canfor Pulp Products Inc. Announces First Quarter 2021 Results   PR Newswire
07:23AM EDT  Colfax: Q1 Earnings Insights   Benzinga
06:21AM EDT  UPDATE: Colfax Narrows, Raises Low End Of FY21 Adj. EPS Guidance From $2-$2.15 To $2.05-$2.15 vs $2.12 Estimate   Benzinga
06:20AM EDT  Colfax Q1 Adj. EPS $0.44 Beats $0.40 Estimate, Sales $879.21M Beat $841.23M Estimate; Raises Guidance   Benzinga
06:00AM EDT  -- Reported $0.19 EPS from continuing operations and achieved $0.44 of adjusted EPS -- Grew sales 8% including organic sales-per-day growth of 9% -- Recently announced expanded fast-growing foot & ankle business with April acquisition of MedShape -- Raising low-end of adjusted 2021 EPS guidance range to $2.05-$2.15   GlobeNewswire Inc
04:10AM EDT  Earnings Scheduled For April 29, 2021   Benzinga
Apr 26, 2021
07:38AM EDT  DJO Completes Acquisition Of MedShape   RTTNews
Apr 14, 2021
01:07PM EDT  Colfax Schedules First Quarter 2021 Earnings Release and   GlobeNewswire Inc
Apr 12, 2021
08:42AM EDT  Morgan Stanley Maintains Equal-Weight on Colfax, Raises Price Target to $45   Benzinga
Apr 6, 2021
10:55AM EDT  Benzinga's Top Ratings Upgrades, Downgrades For April 6, 2021   Benzinga
07:55AM EDT  10 Biggest Price Target Changes For Tuesday   Benzinga
07:48AM EDT  Barclays Downgrades Colfax to Underweight, Lowers Price Target to $45   Benzinga
Apr 1, 2021
06:00PM EDT  Canfor Pulp Products Announces Annual General Meeting and Q1 2021 Results   PR Newswire
06:00PM EDT  Canfor Corporation Announces Annual General Meeting and Q1 2021 Results   PR Newswire
Mar 25, 2021
06:00AM EDT  Colfax Announces Full Redemption of 6.000% Senior Notes due 2024   GlobeNewswire Inc
Mar 17, 2021
05:28AM EDT  Colfax Priced 14M Share Public Offering of Common Stock @$46.00/Share   Benzinga
Mar 16, 2021
11:30PM EDT  Colfax Announces Pricing of Public Offering of 14,000,000 Shares   GlobeNewswire Inc
Mar 15, 2021
04:09PM EDT  Colfax Reports 14M Share Common Stock Offering   Benzinga
04:05PM EDT  Colfax Announces Public Offering of 14,000,000 Shares of Common Stock   GlobeNewswire Inc
Mar 12, 2021
08:24AM EST  10 Biggest Price Target Changes For Friday   Benzinga
05:23AM EST  KeyBanc Maintains Overweight on Colfax, Raises Price Target to $57   Benzinga
Mar 4, 2021
07:04AM EST  Technology company Colfax Corp. (CFX) on Thursday said it plans to separate its fabrication technology and specialty medical technology businesses into two stand-alone, independent and publicly-traded companies. This, according to Colfax, will increase operational flexibility and improve focus on the independent entities.   RTTNews
06:42AM EST  -- Will Create Focused Specialty Medical Technology and Fabrication Technology Companies -- Separation Will Accelerate Strategic Momentum and Unlock Significant Value Creation Potential -- Company Intends Tax-Free Separation to be Completed in the First Quarter of 2022   GlobeNewswire Inc
06:03AM EST  Colfax Announces Intention To Separate Into Two Independent Public Companies; Will Create Focused Specialty Medical Technology And Fabrication Technology Companies   Benzinga
06:02AM EST  Colfax Intends To Separate Its Fabrication Technology And Specialty Medical Technology Businesses   RTTNews
06:00AM EST  -- Will Create Focused Specialty Medical Technology and Fabrication Technology Companies -- Separation Will Accelerate Strategic Momentum and Unlock Significant Value Creation Potential -- Company Intends Tax-Free Separation to be Completed in the First Quarter of 2022   GlobeNewswire Inc
Feb 22, 2021
04:46PM EST  Colfax Corporation (NYSE: CFX), a leading diversified technology company, today announced that it has appointed Philip Okala, Chief Operating Officer of the University of Pennsylvania Health System, to its Board of Directors.This appointment increases the size of Colfaxs Board of Directors to eleven members.   GlobeNewswire Inc
08:55AM EST  Morgan Stanley Maintains Equal-Weight on Colfax, Raises Price Target to $42   Benzinga
Feb 19, 2021
07:31AM EST  Barclays Maintains Equal-Weight on Colfax, Raises Price Target to $40   Benzinga
Feb 18, 2021
07:46AM EST  Colfax: Q4 Earnings Insights   Benzinga
06:02AM EST  Colfax Sees Q1 EPS $0.35-$0.40 To $0.43 Est., FY21 EPS $2.00-$2.15 Vs. $2.02 Est.   Benzinga
06:01AM EST  Colfax Q4 EPS $0.51 Beats $0.50 Estimate, Sales $828.12M Miss $830.72M Estimate   Benzinga
06:00AM EST  Reported $0.29 EPS from continuing operations and achieved $0.51 of adjusted EPS Recently acquired two high-growth, high-gross margin medical technology businesses Announced 2021 outlook with expectations for significant revenue, profit and cash flow growth Scheduled Investor Day for Thursday, March 11, 2021   GlobeNewswire Inc
04:28AM EST  Earnings Scheduled For February 18, 2021   Benzinga
Jan 29, 2021
01:41PM EST  Colfax Schedules Fourth Quarter 2020 Earnings Release and   GlobeNewswire Inc
Jan 19, 2021
07:52PM EST  DJO Buys Trilliant Surgical   RTTNews
07:00PM EST  DJO(r) Acquires Trilliant Surgical   Business Wire
Dec 15, 2020
11:35AM EST  Morgan Stanley Maintains Equal-Weight on Colfax, Raises Price Target to $39   Benzinga
Dec 11, 2020
08:09AM EST  Colfax Subsidiary DJO Acquires LiteCure Laser Therapy; Terms Not Disclosed   Benzinga
08:00AM EST  DJO(r) Acquires LiteCure Laser Therapy   Business Wire
Nov 12, 2020
08:14AM EST  Colfax Subsidiary, DJO Acquires STAR Ankle and Finger Arthroplasty Systems   Benzinga
08:00AM EST  DJO(r) Acquires STAR(r) Ankle and Finger Arthroplasty Systems   Business Wire
Nov 9, 2020
09:38AM EST  Benzinga's Top Upgrades, Downgrades For November 9, 2020   Benzinga
07:14AM EST  UBS Upgrades Colfax to Buy, Announces $40 Price Target   Benzinga
Oct 29, 2020
06:47AM EDT  Colfax Signed Definitive Agreement To Acquire Extremity Product Lines From Stryker For $15M   Benzinga
06:46AM EDT  Colfax Q3 EPS $0.41 Beats $0.38 Estimate, Sales $805.93M Beat $761.05M Estimate   Benzinga
06:00AM EDT  Colfax Reports Third Quarter 2020 Results   GlobeNewswire Inc
04:08AM EDT  Earnings Scheduled For October 29, 2020   Benzinga
Oct 22, 2020
06:15PM EDT  Canfor Pulp Reports Results for Third Quarter of 2020   PR Newswire
Oct 14, 2020
09:14AM EDT  Colfax Schedules Third Quarter 2020 Earnings Release and   GlobeNewswire Inc
Sep 30, 2020
09:33AM EDT  DJO, LLC Announces Launch Of Canal-sparing AltiVate Anatomic CS EDGE Shoulder System   RTTNews
09:29AM EDT  DJO(r) Announces New Stemless Shoulder Offering - the AltiVate(r) Anatomic CS EDGE(tm)   Business Wire
Sep 16, 2020
09:10AM EDT  B of A Securities Maintains Buy on Colfax, Raises Price Target to $42   Benzinga
07:30AM EDT  UBS Initiates Coverage On Colfax with Neutral Rating, Announces Price Target of $36   Benzinga
Aug 20, 2020
07:00AM EDT  DJO(r) Introduces Two New EMPOWR(tm) Systems Designed To Accelerate Surgical Efficiency   Business Wire
Aug 7, 2020
09:34AM EDT  Morgan Stanley Maintains Equal-Weight on Colfax, Raises Price Target to $33   Benzinga
04:45AM EDT  KeyBanc Maintains Overweight on Colfax, Raises Price Target to $36   Benzinga
Aug 6, 2020
04:45PM EDT  DJO(r) Revolutionizes the Orthopedic Journey with the Launch of Motion iQ(tm)   Business Wire
06:23AM EDT  Colfax Q2 Adj. EPS $0.09 Beats $0.05 Estimate, Sales $620.36M Beat $596.46M Estimate   Benzinga
06:00AM EDT  Achieved objectives to address COVID-19 impacts, including generating positive cash flow   GlobeNewswire Inc
Jul 23, 2020
06:00PM EDT  Canfor Pulp Reports Results for Second Quarter of 2020   PR Newswire
Jul 14, 2020
01:56PM EDT  Colfax Schedules Second Quarter 2020 Earnings Release and   GlobeNewswire Inc


Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2025 ChartExchange LLC